PETV Quote, Financials, Valuation and Earnings

Edwards Lifesciences Corp. has a net margin of -765.99% compared to PetVivo Holdings, Inc.'s net margin of 4.09%. PetVivo Holdings, Inc.'s return on equity of -335.08% beat Edwards Lifesciences Corp.'s return on equity of 10.27%.

PetVivo Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 573.4%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $96.93 which suggests that it could grow by 19.59%. Given that PetVivo Holdings, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe PetVivo Holdings, Inc. is more attractive than Edwards Lifesciences Corp..

PetVivo Holdings, Inc. has a beta of 0.393, which suggesting that the stock is 60.679% less volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.946, suggesting its less volatile than the S&P 500 by 5.437%.

PetVivo Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PetVivo Holdings, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.

PetVivo Holdings, Inc. quarterly revenues are $286.1K, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. PetVivo Holdings, Inc.'s net income of -$2.2M is lower than Edwards Lifesciences Corp.'s net income of $64.2M. Notably, PetVivo Holdings, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 44.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetVivo Holdings, Inc. is 19.44x versus 7.80x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.

INVO Fertility, Inc. has a net margin of -765.99% compared to PetVivo Holdings, Inc.'s net margin of -150.51%. PetVivo Holdings, Inc.'s return on equity of -335.08% beat INVO Fertility, Inc.'s return on equity of -471.28%.

PetVivo Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 573.4%. On the other hand INVO Fertility, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 696.81%. Given that INVO Fertility, Inc. has higher upside potential than PetVivo Holdings, Inc., analysts believe INVO Fertility, Inc. is more attractive than PetVivo Holdings, Inc..

PetVivo Holdings, Inc. has a beta of 0.393, which suggesting that the stock is 60.679% less volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.641, suggesting its more volatile than the S&P 500 by 164.106%.

PetVivo Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PetVivo Holdings, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.

PetVivo Holdings, Inc. quarterly revenues are $286.1K, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. PetVivo Holdings, Inc.'s net income of -$2.2M is higher than INVO Fertility, Inc.'s net income of -$2.6M. Notably, PetVivo Holdings, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetVivo Holdings, Inc. is 19.44x versus 0.01x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Nutriband, Inc. has a net margin of -765.99% compared to PetVivo Holdings, Inc.'s net margin of -1118.87%. PetVivo Holdings, Inc.'s return on equity of -335.08% beat Nutriband, Inc.'s return on equity of -164.64%.

PetVivo Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 573.4%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 313.22%. Given that PetVivo Holdings, Inc. has higher upside potential than Nutriband, Inc., analysts believe PetVivo Holdings, Inc. is more attractive than Nutriband, Inc..

PetVivo Holdings, Inc. has a beta of 0.393, which suggesting that the stock is 60.679% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.948, suggesting its more volatile than the S&P 500 by 94.828%.

PetVivo Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. PetVivo Holdings, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

PetVivo Holdings, Inc. quarterly revenues are $286.1K, which are smaller than Nutriband, Inc. quarterly revenues of $346.1K. PetVivo Holdings, Inc.'s net income of -$2.2M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, PetVivo Holdings, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetVivo Holdings, Inc. is 19.44x versus 19.07x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Zimmer Biomet Holdings, Inc. has a net margin of -765.99% compared to PetVivo Holdings, Inc.'s net margin of 6.15%. PetVivo Holdings, Inc.'s return on equity of -335.08% beat Zimmer Biomet Holdings, Inc.'s return on equity of 5.61%.

PetVivo Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 573.4%. On the other hand Zimmer Biomet Holdings, Inc. has an analysts' consensus of $103.00 which suggests that it could grow by 13.32%. Given that PetVivo Holdings, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe PetVivo Holdings, Inc. is more attractive than Zimmer Biomet Holdings, Inc..

PetVivo Holdings, Inc. has a beta of 0.393, which suggesting that the stock is 60.679% less volatile than S&P 500. In comparison Zimmer Biomet Holdings, Inc. has a beta of 0.614, suggesting its less volatile than the S&P 500 by 38.647%.

PetVivo Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zimmer Biomet Holdings, Inc. offers a yield of 1.06% to investors and pays a quarterly dividend of $0.24 per share. PetVivo Holdings, Inc. pays -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc. pays out 27.05% of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

PetVivo Holdings, Inc. quarterly revenues are $286.1K, which are smaller than Zimmer Biomet Holdings, Inc. quarterly revenues of $2.2B. PetVivo Holdings, Inc.'s net income of -$2.2M is lower than Zimmer Biomet Holdings, Inc.'s net income of $137.9M. Notably, PetVivo Holdings, Inc.'s price-to-earnings ratio is -- while Zimmer Biomet Holdings, Inc.'s PE ratio is 25.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for PetVivo Holdings, Inc. is 19.44x versus 2.19x for Zimmer Biomet Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.